HTA on prehospital CT for early diagnosis and treatment of suspected acute stroke in Norway

24

Jul 2019

In June 2019, the Norwegian Institute of Public Health (NIPH) has released a health technology assessment report for prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury, which aimed to summarize and evaluate the documentation for the clinical efficacy and safety of prehospital CT in case of suspected stroke or severe head injuries, and possible initiation of treatment prior to arrival in hospitals, compared with current practice where both imaging and treatment are done in hospitals.

NIPH came to the following conclusions:

  • Compared with conventional care of acute stroke, mobile stroke unit (MSU) care probably reduces the time from a patient’s first contact with the emergency dispatch center to thrombolysis and increases the number of patients who receive thrombolysis. It may also lead to reduced time from a patient’s first contact with the emergency dispatch center to CT imaging, and to a better functionality at 3 months after stroke (mRS score 0-3)
  • With an absolute shortfall of 5.5 QALYs, the argument for giving extra priority to introducing MSU care based on severity is weak-medium, and the societal willingness to pay for MSU according to the suggestion of the Magnussen group can be assumed to be around 385,000 Norwegian kroner per QALY. It was found that the expected cost per QALY is about 385,000 Norwegian kroner or lower if one MSU successfully reaches at least 35-40% (145-171) of thrombolysis patients per year. Decision makers must consider whether they think it is plausible that a minimum of 35-40% of patients could receive the intervention
  • Due to the lack of evidence, the effectiveness of decentralized CT stations outside hospitals and of prehospital CT in suspected severe head injuries is unknown

See the full health technology assessment report in English and Norwegian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more